These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1777547)

  • 1. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations.
    Delchier JC; Vidon N; Saint-Marc Girardin MF; Soule JC; Moulin C; Huchet B; Zylberberg P
    Aliment Pharmacol Ther; 1991 Aug; 5(4):365-78. PubMed ID: 1777547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L; Rodríguez R; Guarner F; Malagelada JR
    Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
    Lieb JG; Patel D; Karnik N; Toskes PP
    Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M; Clague A; Cleghorn GJ; Shepherd RW
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):407-13. PubMed ID: 8145097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
    Opekun AR; Sutton FM; Graham DY
    Aliment Pharmacol Ther; 1997 Oct; 11(5):981-6. PubMed ID: 9354210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.
    Graham DY
    N Engl J Med; 1977 Jun; 296(23):1314-7. PubMed ID: 16212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
    Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
    Trang T; Chan J; Graham DY
    World J Gastroenterol; 2014 Sep; 20(33):11467-85. PubMed ID: 25206255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic enzyme therapy for pancreatic exocrine insufficiency.
    Domínguez-Muñoz JE
    Curr Gastroenterol Rep; 2007 Apr; 9(2):116-22. PubMed ID: 17418056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro study of a new pancreatic enzyme with high lipase content in enteric coated microtablets].
    Vantini I; Fioretta A; Bonfante F; Brentegnani MT; Benini L; Castellani G
    Clin Ter; 1993 May; 142(5):445-51. PubMed ID: 8339528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exocrine pancreatic substitution: facts and controversies.
    Worning H
    Scand J Gastroenterol Suppl; 1986; 126():49-54. PubMed ID: 3470919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP; Dain MP; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.